A short Facebook share with no context on who used the peptides, where it happened or what followed.
Recap by typeshit. Post by Facebook on Facebook.
Benzinga notes a 1.89% after-hours gain for Lilly stock, with Novo Nordisk also tagged. No further detail on what drove the move.
Mikhail Varshavski tells Fox News why protein matters, especially for GLP-1 users. He has a paid partnership with Quest Nutrition.
2:07:50
A live Q&A session covering GLP-1 drugs including Zepbound, Wegovy and Foundayo, with the host taking questions from viewers.
Gen Z use beats every other generation, and appearance was its top reason. Korean regulators are also weighing tighter controls on Wegovy and Mounjaro.
Health and Me ties the Australian actor and stuntman's death to peptides as RFK Jr. moves to loosen US rules on six unapproved peptides over FDA objections.
A short Instagram clip from @realdrbae on side effects he links to the GLOW blend. These are his claims, and the clip itself gives few details.
Loading…